WCP
PFE icon

Wick Capital Partners’s Pfizer PFE Stock Holding History

Wick Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+10,317
New +$270K 0.04% 195
2022
Q2 		– Sell
-7,036
Closed -$364K – 63
2022
Q1 		$364K Buy
7,036
+300
+4% +$15.6K 0.24% 36
2021
Q4 		$398K Buy
+6,736
New +$334K 0.31% 42

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wick Capital Partners's PFE Position: Q2 2026 in Review

Wick Capital Partners opened a new position in Pfizer (PFE) in Q2 2026: 10,317 shares worth $248K. The stake represents 0.04% of the portfolio and ranks #195 among its holdings. This is a return to the name: Wick Capital Partners previously reported a position in PFE as recently as Q1 2022.

Wick Capital Partners first reported a position in PFE in Q4 2021 and has held it in 3 quarters since. The position peaked at $398K in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wick Capital Partners held 10,317 shares of Pfizer worth $248K as of Q2 2026.
  • Pfizer was a new Wick Capital Partners position in Q2 2026.
  • Pfizer made up 0.04% of Wick Capital Partners's portfolio in Q2 2026, its #195 holding.
  • Wick Capital Partners first reported a position in Pfizer in Q4 2021 and has held it in 3 quarters since.
  • Wick Capital Partners's Pfizer position peaked at $398K in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wick Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.